In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV, and HCV), performed on the Tigris testing platform, to the newer Ultrio Elite triplex assay, and performed on the Panther testing platform. The CTS Phoenix lab will implement first on July 7th, with the 4 remaining CTS labs located in Charlotte, Dallas, St. Louis amd Tampa all implementing on July 13, 2020.
Click here for all the details: Communications
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...